James E Flynn - Net Worth and Insider Trading

Over the past 18 months, James E Flynn made 4 insider transaction in Oncorus Inc () with a net sale of 551,663.

In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 551,663 shares of Oncorus Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 551,663 shares.

Oncorus Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made 1 insider transaction in Larimar Therapeutics Inc () with a net purchase of 4,290,617. Other recent insider transactions involving Larimar Therapeutics Inc () include a net purchase of 5,000 shares made by Carole Ben-maimon , a net purchase of 5,000 shares made by Gopi Shankar , and a net purchase of 5,000 shares made by Michael Celano .

In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc () in total and bought 4,292,617 shares, with a net purchase of 4,292,617 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc () were sold and 4,310,367 shares were bought by its insiders, resulting in a net purchase of 4,310,367 shares.

Larimar Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in CalciMedica Inc (). Other recent insider transactions involving CalciMedica Inc () include a net purchase of 65,404 shares made by Eric W Roberts , a net purchase of 20,768 shares made by A. Rachel Leheny , and a net purchase of 691,098 shares made by Fred A Middleton .

In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc () in total and bought 4,000 shares, with a net purchase of 4,000 shares. During the past 18 months, 0 shares of CalciMedica Inc () were sold and 1,505,415 shares were bought by its insiders, resulting in a net purchase of 1,505,415 shares.

CalciMedica Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Acutus Medical Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acutus Medical Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acutus Medical Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Annexon Inc (). Other recent insider transactions involving Annexon Inc () include a net sale of 47,471 shares made by Ted Yednock , a net sale of 7,367 shares made by Jennifer Lew , and a net sale of 5,923 shares made by Michael Overdorf .

In summary, during the past 3 months, insiders sold 17,898 shares of Annexon Inc () in total and bought 3,200 shares, with a net sale of 14,698 shares. During the past 18 months, 73,114 shares of Annexon Inc () were sold and 3,300,258 shares were bought by its insiders, resulting in a net purchase of 3,227,144 shares.

Annexon Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Deerfield Healthcare Technology Acquisitions Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Deerfield Healthcare Technology Acquisitions Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Deerfield Healthcare Technology Acquisitions Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Nkarta Inc (). Other recent insider transactions involving Nkarta Inc () include a net sale of 10,257 shares made by James Trager , a net sale of 5,497 shares made by David Shook , and a net sale of 15,092 shares made by Paul J Hastings .

In summary, during the past 3 months, insiders sold 4,143 shares of Nkarta Inc () in total and bought 5,000,000 shares, with a net purchase of 4,995,857 shares. During the past 18 months, 42,076 shares of Nkarta Inc () were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,957,924 shares.

Nkarta Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Generation Bio Co (). Other recent insider transactions involving Generation Bio Co () include a net sale of 13,504 shares made by Antoinette Paone , a net purchase of 20,000 shares made by Dannielle Appelhans , and a net purchase of 342,960 shares made by Rowland Charles A Jr .

In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,369 shares of Generation Bio Co () were sold and 551,455 shares were bought by its insiders, resulting in a net purchase of 536,086 shares.

Generation Bio Co ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Lumos Pharma Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lumos Pharma Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Lumos Pharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of DFP Healthcare Acquisitions Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DFP Healthcare Acquisitions Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DFP Healthcare Acquisitions Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Revolution Medicines Inc (). Other recent insider transactions involving Revolution Medicines Inc () include a net sale of 144,946 shares made by Margaret A Horn , a net sale of 97,493 shares made by Stephen Michael Kelsey , and a net sale of 12,934 shares made by Jeff Cislini .

In summary, during the past 3 months, insiders sold 58,164 shares of Revolution Medicines Inc () in total and bought 0 shares, with a net sale of 58,164 shares. During the past 18 months, 380,492 shares of Revolution Medicines Inc () were sold and 650,000 shares were bought by its insiders, resulting in a net purchase of 269,508 shares.

Revolution Medicines Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Schrodinger Inc (). Other recent insider transactions involving Schrodinger Inc () include a net sale of 60,758 shares made by Yvonne Tran , a net sale of 20,901 shares made by Kenneth Patrick Lorton , and a net sale of 66,886 shares made by Ramy Farid .

In summary, during the past 3 months, insiders sold 6,966 shares of Schrodinger Inc () in total and bought 0 shares, with a net sale of 6,966 shares. During the past 18 months, 168,702 shares of Schrodinger Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 168,702 shares.

Schrodinger Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Black Diamond Therapeutics Inc (). Other recent insider transactions involving Black Diamond Therapeutics Inc () include a net purchase of 3,604,453 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,000 shares of Black Diamond Therapeutics Inc () were sold and 5,596,666 shares were bought by its insiders, resulting in a net purchase of 5,571,666 shares.

Black Diamond Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Homology Medicines Inc (). Other recent insider transactions involving Homology Medicines Inc () include a net sale of 21,335 shares made by Paul Alloway , a net sale of 23,653 shares made by Arthur Tzianabos , and a net sale of 5,068 shares made by Albert Seymour .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,328 shares of Homology Medicines Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,328 shares.

Homology Medicines Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of AdaptHealth Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AdaptHealth Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AdaptHealth Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Cabaletta Bio Inc (). Other recent insider transactions involving Cabaletta Bio Inc () include a net sale of 110,000 shares made by Gwendolyn Binder ,

In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110,000 shares of Cabaletta Bio Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 110,000 shares.

Cabaletta Bio Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Frequency Therapeutics Inc (). Other recent insider transactions involving Frequency Therapeutics Inc () include a net sale of 97,675 shares made by David L. Lucchino , a net sale of 8,202 shares made by Richard J. Mitrano , and a net sale of 26,723 shares made by Christopher R. Loose .

In summary, during the past 3 months, insiders sold 0 shares of Frequency Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,600 shares of Frequency Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,600 shares.

Frequency Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Mirum Pharmaceuticals Inc (). Other recent insider transactions involving Mirum Pharmaceuticals Inc () include a net sale of 10,305 shares made by Peter Radovich , a net sale of 8,137 shares made by Jolanda Howe , and a net purchase of 161,963 shares made by Patrick J Heron .

In summary, during the past 3 months, insiders sold 14,902 shares of Mirum Pharmaceuticals Inc () in total and bought 4,000 shares, with a net sale of 10,902 shares. During the past 18 months, 393,444 shares of Mirum Pharmaceuticals Inc () were sold and 175,963 shares were bought by its insiders, resulting in a net sale of 217,481 shares.

Mirum Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Aclaris Therapeutics Inc (). Other recent insider transactions involving Aclaris Therapeutics Inc () include a net sale of 53,837 shares made by Joseph Monahan , a net sale of 129,240 shares made by Neal Walker , and a net sale of 95,100 shares made by Andrew N Schiff .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 284,338 shares of Aclaris Therapeutics Inc () were sold and 36,995 shares were bought by its insiders, resulting in a net sale of 247,343 shares.

Aclaris Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Shockwave Medical Inc (). Other recent insider transactions involving Shockwave Medical Inc () include a net sale of 76,000 shares made by Isaac Zacharias , a net sale of 49,000 shares made by Frank T Watkins , and a net sale of 21,113 shares made by Dan Puckett .

In summary, during the past 3 months, insiders sold 97,042 shares of Shockwave Medical Inc () in total and bought 0 shares, with a net sale of 97,042 shares. During the past 18 months, 316,716 shares of Shockwave Medical Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 316,716 shares.

Shockwave Medical Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Xeris Biopharma Holdings Inc (). Other recent insider transactions involving Xeris Biopharma Holdings Inc () include a net purchase of 30,000 shares made by Paul R Edick , a net purchase of 11,000 shares made by John P. Schmid , and a net purchase of 30,769 shares made by Shannon John Patrick Jr .

In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc () in total and bought 4,500 shares, with a net purchase of 4,500 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc () were sold and 110,579 shares were bought by its insiders, resulting in a net purchase of 110,579 shares.

Xeris Biopharma Holdings Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Arvinas Inc (). Other recent insider transactions involving Arvinas Inc () include a net sale of 11,074 shares made by John G Houston , a net sale of 3,447 shares made by Sean A Cassidy , and a net sale of 3,023 shares made by Ronald Peck .

In summary, during the past 3 months, insiders sold 10,298 shares of Arvinas Inc () in total and bought 0 shares, with a net sale of 10,298 shares. During the past 18 months, 20,296 shares of Arvinas Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 20,296 shares.

Arvinas Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerie Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Avadel Pharmaceuticals PLC (). Other recent insider transactions involving Avadel Pharmaceuticals PLC () include a net purchase of 9,000 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 33,000 shares made by Eric J Ende .

In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC () were sold and 70,500 shares were bought by its insiders, resulting in a net sale of 33,475 shares.

Avadel Pharmaceuticals PLC ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Protara Therapeutics Inc (). Other recent insider transactions involving Protara Therapeutics Inc () include a net sale of 15,473 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,473 shares of Protara Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 15,473 shares.

Protara Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Kiniksa Pharmaceuticals Ltd (). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd () include a net sale of 96,513 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .

In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd () in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd () were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.

Kiniksa Pharmaceuticals Ltd ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mallinckrodt PLC ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Rhythm Pharmaceuticals Inc (). Other recent insider transactions involving Rhythm Pharmaceuticals Inc () include a net sale of 81,925 shares made by Jennifer Chien , a net sale of 154,303 shares made by Joseph Shulman , and a net sale of 72,562 shares made by Hunter C Smith .

In summary, during the past 3 months, insiders sold 252,926 shares of Rhythm Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 252,926 shares. During the past 18 months, 404,456 shares of Rhythm Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 404,456 shares.

Rhythm Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Societal CDMO Inc (). Other recent insider transactions involving Societal CDMO Inc () include a net sale of 230,000 shares made by Awm Investment Company, Inc. , a net purchase of 125,660 shares made by Enloe J David Jr , and a net purchase of 6,250,000 shares made by Mathew Paul Arens .

In summary, during the past 3 months, insiders sold 0 shares of Societal CDMO Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 370,000 shares of Societal CDMO Inc () were sold and 6,792,882 shares were bought by its insiders, resulting in a net purchase of 6,422,882 shares.

Societal CDMO Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in eHealth Inc (). Other recent insider transactions involving eHealth Inc () include a net purchase of 22,932 shares made by Dale B Wolf , a net purchase of 7,500 shares made by Gavin G. Galimi , and a net purchase of 80,000 shares made by Soistman Francis S Jr .

In summary, during the past 3 months, insiders sold 0 shares of eHealth Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,000 shares of eHealth Inc () were sold and 115,432 shares were bought by its insiders, resulting in a net purchase of 110,432 shares.

eHealth Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of CAS Medical Systems Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CAS Medical Systems Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CAS Medical Systems Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Invuity Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Invuity Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Invuity Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Vanda Pharmaceuticals Inc (). Other recent insider transactions involving Vanda Pharmaceuticals Inc () include a net sale of 51,638 shares made by Kevin Patrick Moran , a net sale of 56,426 shares made by Timothy Williams , and a net sale of 196,036 shares made by Mihael Hristos Polymeropoulos .

In summary, during the past 3 months, insiders sold 121,098 shares of Vanda Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 121,098 shares. During the past 18 months, 377,072 shares of Vanda Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 377,072 shares.

Vanda Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Alpine Immune Sciences Inc (). Other recent insider transactions involving Alpine Immune Sciences Inc () include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Peter A. Thompson .

In summary, during the past 3 months, insiders sold 118,000 shares of Alpine Immune Sciences Inc () in total and bought 0 shares, with a net sale of 118,000 shares. During the past 18 months, 3,587,510 shares of Alpine Immune Sciences Inc () were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,510 shares.

Alpine Immune Sciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Audentes Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Audentes Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Audentes Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Axogen Inc (). Other recent insider transactions involving Axogen Inc () include a net sale of 100,448 shares made by Gregory Gene Freitag , a net sale of 128,948 shares made by Peter J Mariani , and a net sale of 42,343 shares made by Michael Patrick Donovan .

In summary, during the past 3 months, insiders sold 118,082 shares of Axogen Inc () in total and bought 0 shares, with a net sale of 118,082 shares. During the past 18 months, 322,478 shares of Axogen Inc () were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 292,478 shares.

Axogen Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Syros Pharmaceuticals Inc (). Other recent insider transactions involving Syros Pharmaceuticals Inc () include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net sale of 689 shares made by Eric R Olson .

In summary, during the past 3 months, insiders sold 10,601 shares of Syros Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 10,601 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc () were sold and 904,977 shares were bought by its insiders, resulting in a net purchase of 873,765 shares.

Syros Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of XenoPort Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XenoPort Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XenoPort Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of AveXis Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AveXis Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AveXis Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Editas Medicine Inc (). Other recent insider transactions involving Editas Medicine Inc () include a net sale of 6,936 shares made by Bruce Eaton , a net sale of 7,365 shares made by Michelle Robertson , and a net sale of 84,310 shares made by Gilmore Neil O'neill .

In summary, during the past 3 months, insiders sold 98,151 shares of Editas Medicine Inc () in total and bought 0 shares, with a net sale of 98,151 shares. During the past 18 months, 126,045 shares of Editas Medicine Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 126,045 shares.

Editas Medicine Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Streamline Health Solutions Inc (). Other recent insider transactions involving Streamline Health Solutions Inc () include a net purchase of 757,575 shares made by Kenan Lucas ,

In summary, during the past 3 months, insiders sold 0 shares of Streamline Health Solutions Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Streamline Health Solutions Inc () were sold and 757,575 shares were bought by its insiders, resulting in a net purchase of 757,575 shares.

Streamline Health Solutions Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Alimera Sciences Inc (). Other recent insider transactions involving Alimera Sciences Inc () include a net sale of 0 shares made by Caligan Partners Lp , a net purchase of 1,401,901 shares made by Adam Morgan , and a net sale of 200,919 shares made by Palo Alto Investors, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 779,919 shares of Alimera Sciences Inc () were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,200,982 shares.

Alimera Sciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in CytomX Therapeutics Inc (). Other recent insider transactions involving CytomX Therapeutics Inc () include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,868 shares made by Lloyd A Rowland , and a net sale of 16,235 shares made by Jeffrey B Landau .

In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc () in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc () were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.

CytomX Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antares Pharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Regenxbio Inc (). Other recent insider transactions involving Regenxbio Inc () include a net sale of 135,000 shares made by Kenneth T. Mills , and a net sale of 12,878 shares made by Steve Pakola .

In summary, during the past 3 months, insiders sold 57,878 shares of Regenxbio Inc () in total and bought 0 shares, with a net sale of 57,878 shares. During the past 18 months, 147,878 shares of Regenxbio Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 147,878 shares.

Regenxbio Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neos Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in aTyr Pharma Inc (). Other recent insider transactions involving aTyr Pharma Inc () include a net purchase of 55,000 shares made by Sanjay Shukla , a net sale of 3,156 shares made by Jill Marie Broadfoot , and a net purchase of 200,000 shares made by Paul Schimmel .

In summary, during the past 3 months, insiders sold 1,590 shares of aTyr Pharma Inc () in total and bought 0 shares, with a net sale of 1,590 shares. During the past 18 months, 3,156 shares of aTyr Pharma Inc () were sold and 255,000 shares were bought by its insiders, resulting in a net purchase of 251,844 shares.

aTyr Pharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of SteadyMed Ltd () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SteadyMed Ltd () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SteadyMed Ltd ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Invitae Corp (). Other recent insider transactions involving Invitae Corp () include a net sale of 92,717 shares made by Kenneth D. Knight , a net sale of 89,529 shares made by Yafei Wen , and a net sale of 36,187 shares made by Robert L Nussbaum .

In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 332,151 shares of Invitae Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 332,151 shares.

Invitae Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dicerna Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Loxo Oncology Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Adverum Biotechnologies Inc (). Other recent insider transactions involving Adverum Biotechnologies Inc () include a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , a net purchase of 100,000 shares made by Linda M Rubinstein , and a net purchase of 100,000 shares made by James Paul Scopa .

In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc () in total and bought 23,000 shares, with a net purchase of 23,000 shares. During the past 18 months, 6,810 shares of Adverum Biotechnologies Inc () were sold and 33,000 shares were bought by its insiders, resulting in a net purchase of 26,190 shares.

Adverum Biotechnologies Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of NxStage Medical Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NxStage Medical Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NxStage Medical Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Rigel Pharmaceuticals Inc (). Other recent insider transactions involving Rigel Pharmaceuticals Inc () include a net sale of 73,234 shares made by Raul R Rodriguez , a net sale of 19,907 shares made by David A Santos , and a net sale of 18,017 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 80,041 shares of Rigel Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 80,041 shares. During the past 18 months, 116,547 shares of Rigel Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,547 shares.

Rigel Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of The Medicines Co () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of The Medicines Co () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

The Medicines Co ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of NeuroMetrix Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeuroMetrix Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NeuroMetrix Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Fibrocell Science Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fibrocell Science Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Fibrocell Science Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of NeurogesX Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeurogesX Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NeurogesX Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Cyclacel Pharmaceuticals Inc (). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc () include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc () were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Dynavax Technologies Corp (). Other recent insider transactions involving Dynavax Technologies Corp () include a net sale of 238,719 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 4,500,000 shares made by Hack Andrew A. F. .

In summary, during the past 3 months, insiders sold 20,526 shares of Dynavax Technologies Corp () in total and bought 0 shares, with a net sale of 20,526 shares. During the past 18 months, 4,836,004 shares of Dynavax Technologies Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,836,004 shares.

Dynavax Technologies Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of VIA Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VIA Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

VIA Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Arena Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arena Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arena Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Edgewise Therapeutics Inc (). Other recent insider transactions involving Edgewise Therapeutics Inc () include a net sale of 40,229 shares made by John R Moore , a net sale of 174,187 shares made by Alan J Russell , and a net sale of 91,336 shares made by R Michael Carruthers .

In summary, during the past 3 months, insiders sold 39,835 shares of Edgewise Therapeutics Inc () in total and bought 0 shares, with a net sale of 39,835 shares. During the past 18 months, 323,956 shares of Edgewise Therapeutics Inc () were sold and 919,947 shares were bought by its insiders, resulting in a net purchase of 595,991 shares.

Edgewise Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made 1 insider transaction in AdaptHealth Corp () with a net sale of 350,000. Other recent insider transactions involving AdaptHealth Corp () include a net sale of 1,575,473 shares made by Everest Hill Group Inc. , a net sale of 325,627 shares made by Skyknight Aero Holdings, Llc , and a net sale of 200,000 shares made by Albert A. Prast .

In summary, during the past 3 months, insiders sold 350,000 shares of AdaptHealth Corp () in total and bought 0 shares, with a net sale of 350,000 shares. During the past 18 months, 2,643,433 shares of AdaptHealth Corp () were sold and 720 shares were bought by its insiders, resulting in a net sale of 2,642,713 shares.

AdaptHealth Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Werewolf Therapeutics Inc (). Other recent insider transactions involving Werewolf Therapeutics Inc () include a net purchase of 1,853,000 shares made by Ra Capital Healthcare Fund Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Werewolf Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Werewolf Therapeutics Inc () were sold and 1,853,000 shares were bought by its insiders, resulting in a net purchase of 1,853,000 shares.

Werewolf Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in The Oncology Institute Inc (). Other recent insider transactions involving The Oncology Institute Inc () include a net sale of 1,098,487 shares made by Havencrest Healthcare Partners, L.p. , a net sale of 81,718 shares made by Brad Hively , and a net purchase of 73,107 shares made by Matthew P Miller .

In summary, during the past 3 months, insiders sold 52,413 shares of The Oncology Institute Inc () in total and bought 0 shares, with a net sale of 52,413 shares. During the past 18 months, 1,205,730 shares of The Oncology Institute Inc () were sold and 223,684 shares were bought by its insiders, resulting in a net sale of 982,046 shares.

The Oncology Institute Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in CareMax Inc (). Other recent insider transactions involving CareMax Inc () include a net purchase of 10,000 shares made by Bryan Cho ,

In summary, during the past 3 months, insiders sold 0 shares of CareMax Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CareMax Inc () were sold and 333 shares were bought by its insiders, resulting in a net purchase of 333 shares.

CareMax Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Terns Pharmaceuticals Inc (). Other recent insider transactions involving Terns Pharmaceuticals Inc () include a net purchase of 10,743 shares made by Mark J. Vignola , a net purchase of 10,743 shares made by Seokho Bryan Yoon , and a net purchase of 337,957 shares made by Vivo Opportunity Fund Holdings, L.p. .

In summary, during the past 3 months, insiders sold 420,663 shares of Terns Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 420,663 shares. During the past 18 months, 1,920,663 shares of Terns Pharmaceuticals Inc () were sold and 1,816,702 shares were bought by its insiders, resulting in a net sale of 103,961 shares.

Terns Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in PepGen Inc (). Other recent insider transactions involving PepGen Inc () include a net sale of 29,556 shares made by James G Mcarthur , a net sale of 6,392 shares made by Jaya Goyal , and a net purchase of 2,557,593 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 0 shares of PepGen Inc () in total and bought 2,557,593 shares, with a net purchase of 2,557,593 shares. During the past 18 months, 37,642 shares of PepGen Inc () were sold and 2,559,287 shares were bought by its insiders, resulting in a net purchase of 2,521,645 shares.

PepGen Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Xilio Therapeutics Inc (). Other recent insider transactions involving Xilio Therapeutics Inc () include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 1,000 shares of Xilio Therapeutics Inc () in total and bought 485,250 shares, with a net purchase of 484,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc () were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Singular Genomics Systems Inc (). Other recent insider transactions involving Singular Genomics Systems Inc () include a net purchase of 420,000 shares made by Eli N. Glezer , a net sale of 631,648 shares made by Kim P. Kamdar , and a net purchase of 118,468 shares made by Andrew Spaventa .

In summary, during the past 3 months, insiders sold 0 shares of Singular Genomics Systems Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 631,648 shares of Singular Genomics Systems Inc () were sold and 538,468 shares were bought by its insiders, resulting in a net sale of 93,180 shares.

Singular Genomics Systems Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made 1 insider transaction in Nuvalent Inc () with a net purchase of 650,000. Other recent insider transactions involving Nuvalent Inc () include a net sale of 136,400 shares made by Darlene Noci , a net sale of 103,546 shares made by Deborah Ann Miller , and a net sale of 541,994 shares made by Matthew Shair .

In summary, during the past 3 months, insiders sold 1,095,333 shares of Nuvalent Inc () in total and bought 0 shares, with a net sale of 1,095,333 shares. During the past 18 months, 1,763,833 shares of Nuvalent Inc () were sold and 799,253 shares were bought by its insiders, resulting in a net sale of 964,580 shares.

Nuvalent Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of DA32 Life Science Tech Acquisition Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DA32 Life Science Tech Acquisition Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DA32 Life Science Tech Acquisition Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Mallinckrodt PLC (). Other recent insider transactions involving Mallinckrodt PLC () include a net purchase of 30,000 shares made by James R Sulat , a net purchase of 5,000 shares made by Paul Bisaro , and a net purchase of 3,000 shares made by Sigurdur O Olafsson .

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC () were sold and 40,133 shares were bought by its insiders, resulting in a net purchase of 40,133 shares.

Mallinckrodt PLC ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Silverback Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Peak Bio Inc (). Other recent insider transactions involving Peak Bio Inc () include a net purchase of 190,250 shares made by Hoyoung Huh ,

In summary, during the past 3 months, insiders sold 0 shares of Peak Bio Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Peak Bio Inc () were sold and 190,250 shares were bought by its insiders, resulting in a net purchase of 190,250 shares.

Peak Bio Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.